The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Holubiak Myron Z since 2007.
The trader's CIK number is 1199080.
At the time of the last reporting, Holubiak Myron Z was the Director of Citius Pharmaceuticals, Inc.. (stock ticker symbol CTXR).
Also see all insider trading activities at Citius Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2019 | CTXR | 688,047 | $699,944 | 0 | $0 | 0 | $0 |
2018 | CTXR | 787,229 | $1,009,007 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2016 | BIOS | 0 | $0 | 0 | $0 | 10,000 | $0 |
2014 | BIOS | 0 | $0 | 5,000 | $39,700 | 5,000 | $26,650 |
2013 | BIOS | 0 | $0 | 31,200 | $509,714 | 31,200 | $227,448 |
2012 | BIOS | 0 | $0 | 26,400 | $247,723 | 16,400 | $70,694 |
2011 | BIOS | 0 | $0 | 8,500 | $46,138 | 0 | $0 |
2010 | BIOS | 0 | $0 | 5,000 | $34,000 | 0 | $0 |
2007 | BIOS | 0 | $0 | 20,000 | $175,420 | 20,000 | $85,600 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2007 | NSTK | 0 | $0 | 3,000 | $42,567 | 0 | $0 |
1. Citius Pharmaceuticals, Inc. (CTXR)
2. Option Care Health, Inc. (BIOS)
3. Nastech Pharmaceutical Co Inc (NSTK)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2019-09-27 | CTXR | Buy | 558,597 | .90 | 499,944 |
2019-04-03 | CTXR | Buy | 129,450 | 1.54 | 200,000 |
2018-08-13 | CTXR | Buy | 784,314 | 1.27 | 1,000,000 |
2018-03-28 | CTXR | Buy | 2,915 | 3.09 | 9,007 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2016-05-31 | BIOS | Option Ex | 10,000 | .00 | 0 |
2014-06-16 | BIOS | Sale | 5,000 | 7.94 | 39,700 |
2014-06-16 | BIOS | Option Ex | 5,000 | 5.33 | 26,650 |
2013-07-19 | BIOS | Option Ex | 31,200 | 7.29 | 227,448 |
2013-07-19 | BIOS | Sale | 31,200 | 16.34 | 509,714 |
2012-12-14 | BIOS | Sale | 10,000 | 10.82 | 108,230 |
2012-09-06 | BIOS | Sale | 8,400 | 8.51 | 71,467 |
2012-09-07 | BIOS | Sale | 1,200 | 8.50 | 10,200 |
2012-09-06 | BIOS | Option Ex | 8,400 | 4.28 | 35,952 |
2012-09-07 | BIOS | Option Ex | 1,200 | 4.28 | 5,136 |
2012-09-04 | BIOS | Sale | 100 | 8.50 | 850 |
2012-08-31 | BIOS | Sale | 6,700 | 8.50 | 56,976 |
2012-09-04 | BIOS | Option Ex | 100 | 4.28 | 428 |
2012-08-31 | BIOS | Option Ex | 6,700 | 4.36 | 29,178 |
2011-12-15 | BIOS | Sale | 8,500 | 5.43 | 46,138 |
2010-06-15 | BIOS | Sale | 5,000 | 6.80 | 34,000 |
2007-12-14 | BIOS | Option Ex | 20,000 | 4.28 | 85,600 |
2007-12-14 | BIOS | Sale | 20,000 | 8.77 | 175,420 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2007-08-15 | NSTK | Sale | 3,000 | 14.19 | 42,567 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Holubiak Myron Z (Director of Citius Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.